GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
2.320
+0.040 (1.75%)
At close: Apr 28, 2026, 4:00 PM EDT
2.350
+0.030 (1.29%)
Pre-market: Apr 29, 2026, 4:30 AM EDT
GoodRx Holdings Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for GoodRx Holdings stock have an average target of 3.66, with a low estimate of 2.50 and a high estimate of 6.00. The average target predicts an increase of 57.76% from the current stock price of 2.32.
Analyst Consensus: Buy
* Price targets were last updated on Mar 4, 2026.
Analyst Ratings
The average analyst rating for GoodRx Holdings stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 3 | 2 | 1 | 1 | 1 |
| Hold | 5 | 5 | 6 | 7 | 7 | 6 |
| Sell | 0 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 10 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $7 → $3.5 | Buy | Maintains | $7 → $3.5 | +50.86% | Mar 4, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $4.5 → $3.5 | Strong Buy | Maintains | $4.5 → $3.5 | +50.86% | Mar 3, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $4 → $2.5 | Hold | Maintains | $4 → $2.5 | +7.76% | Mar 2, 2026 |
| Mizuho | Mizuho | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +29.31% | Feb 27, 2026 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 27, 2026 |
Financial Forecast
Revenue This Year
779.73M
from 796.85M
Decreased by -2.15%
Revenue Next Year
821.68M
from 779.73M
Increased by 5.38%
EPS This Year
0.32
from 0.09
Increased by 277.82%
EPS Next Year
0.37
from 0.32
Increased by 16.04%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 813.1M | 871.9M | |||||
| Avg | 779.7M | 821.7M | |||||
| Low | 738.0M | 754.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 2.0% | 11.8% | |||||
| Avg | -2.1% | 5.4% | |||||
| Low | -7.4% | -3.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 0.40 | 0.50 | ||
| Avg | 0.32 | 0.37 | ||
| Low | 0.26 | 0.28 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 367.1% | 56.2% | ||
| Avg | 277.8% | 16.0% | ||
| Low | 209.7% | -11.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.